Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
875
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Romiplostim use for thrombocytopenia following allogeneic hematopoietic stem cell transplantation: a case series from a single center in Qatar

Abdulrahman F. Al-MashdaliNational Center for Cancer Care and Research, Department of Oncology, Hematology and BMT Section, Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1393-5302View further author information
ORCID Icon,
Amaal GuliedNational Center for Cancer Care and Research, Department of Oncology, Hematology and BMT Section, Hamad Medical Corporation, Doha, QatarView further author information
,
Mohammed M. BakrNational Center for Cancer Care and Research, Department of Oncology, Hematology and BMT Section, Hamad Medical Corporation, Doha, QatarView further author information
&
Mohamed A. YassinNational Center for Cancer Care and Research, Department of Oncology, Hematology and BMT Section, Hamad Medical Corporation, Doha, QatarView further author information
Article: 2280872 | Received 26 Aug 2023, Accepted 02 Nov 2023, Published online: 14 Nov 2023

References

  • Bento L, Canaro M, Bastida JM, et al. Thrombocytopenia and therapeutic strategies after allogeneic hematopoietic stem cell transplantation. J Clin Med. 2022;11:1364. doi:10.3390/jcm11051364
  • Bruno B, Gooley T, Sullivan KM, et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:154–162. doi:10.1053/bbmt.2001.v7.pm11302549
  • Kırcalı E, Cengiz Seval G, Öztürk C, et al. Eltrombopag for the treatment of poor graft function following haematopoietic cell transplantation: real-life data. Balkan Med J. 2023;40:51–56. doi:10.4274/balkanmedj.galenos.2022.2022-2-48
  • Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American society for transplantation and cellular therapy. Transplant Cell Ther. 2021;27:642–649. doi:10.1016/j.jtct.2021.04.007
  • Huang L, Xu J, Zhang H, et al. Application and investigation of thrombopoiesis-stimulating agents in the treatment of thrombocytopenia. Ther Adv Hematol. 2023;14:20406207231152744. doi:10.1177/20406207231152746
  • Samarkandi H, Al Nahedh M, Alfattani A, et al. Evaluation of eltrombopag in thrombocytopenia post hematopoietic cell transplantation: rertrospective observational trial. Hematol Oncol Stem Cell Ther. 2022;15:285–290.
  • Mahat U, Rotz SJ, Hanna R. Use of thrombopoietin receptor agonists in prolonged thrombocytopenia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020;26:e65–e73. doi:10.1016/j.bbmt.2019.12.003
  • Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013;98:10–23. doi:10.1007/s12185-013-1382-0
  • Ghanima W, Cooper N, Rodeghiero F, et al. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104:1112–1123. doi:10.3324/haematol.2018.212845
  • Kuter DJ, Bussel JB, Newland A, et al. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol. 2013;161:411–423. doi:10.1111/bjh.12260
  • Rodeghiero F. Is ITP a thrombophilic disorder? Am J Hematol. 2016;91:39–45. doi:10.1002/ajh.24234
  • Scordo M, Gilbert LJ, Hanley DM, et al. Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Adv. 2023; 7:1536–1544. doi:10.1182/bloodadvances.2022007838
  • Peffault de Latour R, Chevret S, Ruggeri AL, et al. Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial. Blood. 2020;135:227–229. doi:10.1182/blood.2019000358
  • Capecchi M, Serpenti F, Giannotta J, et al. Off-label use of thrombopoietin receptor agonists: case series and review of the literature. Front Oncol. 2021;11:680411. doi:10.3389/fonc.2021.680411

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.